Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by lscfaon Jan 06, 2023 12:17pm
135 Views
Post# 35207117

RE:RE:RE:RE:News

RE:RE:RE:RE:News
qwerty22 wrote:

You mean like Lisa who speculates/claims revenue was hit by Covid and hurricanes? Who speculates, I mean issues guidance, that revenue will be through the roof and it's far from that. If she can see that in the data I'd like to see it. If she's just speculating I'd like to know that. I'd like to know the business model is firing on all cylinders but they got unlucky. I suspect that's not how it is.

I'd like to see SaaS properly separated out. It's meant to be recurring. It should be growing with growing on-boarding. Their numbers are being saved/obscured by hardware atm. They must see the trajectory of SaaS in the data, I can't see it in the Quarterlies. Well nothing that comes close to past guidance. 

What you are saying is pretty much what I want, I want to see the monthly variation. I want to see the Covid hit to revenue coming through when the Covid wave came through. I want to see the revenue from the month after the Covid wave take a massive hit as she asserts. I want to see it recover as onboarded patients get back to being revenue generators as she assert. The whole point is she is saying SaaS revenue was growing but it took these massive, time-specific hits. I want to see evidence for that. It's not there in the quarterlies.

I want to see all this because her ability to fully tell the truth is in doubt atm. Outside a few oddballs on this site she is about the most speculative person around this stock. Her guidance is about as bad as it can be. Do you not see that?


Lifeboat1 wrote: Query22 - Quarterly revenue has only been 2 steps
forward for 18 months.  There have been no steps back.  The data is available to the end of September.

if you had any business sense you would know that there is always monthly variations which is why Companies generally only report quarterly to smooth out those variations to give investors a more accurate picture of progress and keep speculations and conspiracy theorist from making claims from 1 month of data that is not accurate.

 


You can see the COVID hit in Jun qtr sass....

 

Qtr ending

Sep 22

Jun 22

Mar 22

Dec 21

Sept 21

SAAS rev

1,422,671

783,659

1,067,426

524,547

363,884

device rev - returns

2,049,566

1,504,843

1,447,587

1,615,577

1,244,284

SAAS cost

142,292

677,567

640,533

142,713

123,434

 device cost

1,155,350

1,666,256

238,376

413,709

325,710

SAAS margin

90.0%

13.5%

40.0%

72.8%

66.1%

device margin

43.6%

(10.7%)

83.5%

74.4%

73.8%

Gross profit 

2,174,595

922,474

1,636,104

1,583,702

1,159,024

Expenses

(2,908,106)

(2,181,647)

(2,427,609)

(3,616,207)

(5,406,869)

Income (Loss)

(733,511)

(1,259,173)

(791,505)

(2,032,505)

(4,247,845)

Fx & int income

611,036

264,277

(19,537)

(122,606)

37,913

Comp. loss

(122,475)

(994,896)

(811,042)

(2,155,111)

(4,209,932)

 

<< Previous
Bullboard Posts
Next >>